111, Inc. (YI)
USD 8.4
(1.82%)
USD 8.4
(1.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -350.09 Million CNY | 5.63% |
| 2022 | -371 Million CNY | 42.22% |
| 2021 | -642.14 Million CNY | -35.67% |
| 2020 | -473.31 Million CNY | 4.09% |
| 2019 | -493.51 Million CNY | -23.26% |
| 2018 | -400.37 Million CNY | -57.61% |
| 2017 | -254.02 Million CNY | 30.27% |
| 2016 | -364.28 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 3.33 Million CNY | -10.37% |
| 2024 Q1 | 3.72 Million CNY | 101.8% |
| 2023 FY | -350.09 Million CNY | 5.63% |
| 2023 Q1 | -21.73 Million CNY | 79.96% |
| 2023 Q2 | -41.4 Million CNY | -90.53% |
| 2023 Q3 | -80.42 Million CNY | -94.23% |
| 2023 Q4 | -206.53 Million CNY | -156.82% |
| 2022 FY | -371 Million CNY | 42.22% |
| 2022 Q2 | -79.75 Million CNY | 21.93% |
| 2022 Q4 | -108.42 Million CNY | -34.41% |
| 2022 Q3 | -80.66 Million CNY | -1.15% |
| 2022 Q1 | -102.15 Million CNY | 2.43% |
| 2021 Q1 | -173.26 Million CNY | -19.72% |
| 2021 FY | -642.14 Million CNY | -35.67% |
| 2021 Q3 | -175.35 Million CNY | 7.13% |
| 2021 Q4 | -104.69 Million CNY | 40.3% |
| 2021 Q2 | -188.82 Million CNY | -8.98% |
| 2020 Q1 | -113.69 Million CNY | 32.35% |
| 2020 Q3 | -122.18 Million CNY | -31.79% |
| 2020 Q4 | -144.72 Million CNY | -18.45% |
| 2020 FY | -473.31 Million CNY | 4.09% |
| 2020 Q2 | -92.71 Million CNY | 18.46% |
| 2019 Q2 | -100.83 Million CNY | 5.32% |
| 2019 FY | -493.51 Million CNY | -23.26% |
| 2019 Q1 | -106.5 Million CNY | 19.44% |
| 2019 Q4 | -168.07 Million CNY | -42.32% |
| 2019 Q3 | -118.09 Million CNY | -17.11% |
| 2018 Q2 | -96.08 Million CNY | -127.83% |
| 2018 Q4 | -132.21 Million CNY | -1.78% |
| 2018 Q1 | -42.17 Million CNY | 36.2% |
| 2018 Q3 | -129.9 Million CNY | -35.19% |
| 2018 FY | -400.37 Million CNY | -57.61% |
| 2017 Q2 | -60.56 Million CNY | 2.39% |
| 2017 FY | -254.02 Million CNY | 30.27% |
| 2017 Q4 | -66.1 Million CNY | -1.22% |
| 2017 Q1 | -62.04 Million CNY | 0.0% |
| 2017 Q3 | -65.3 Million CNY | -7.83% |
| 2016 FY | -364.28 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -13.47 Million USD | -2497.641% |
| China Jo-Jo Drugstores, Inc. | -3.53 Million USD | -9804.959% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 580 Thousand USD | 60461.552% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 431 Thousand USD | 81329.002% |
| Leafly Holdings, Inc. | -7.05 Million USD | -4865.211% |
| LifeMD, Inc. | -14.48 Million USD | -2316.25% |
| LifeMD, Inc. | -14.48 Million USD | -2316.25% |
| TRxADE HEALTH, Inc. | -7.26 Million USD | -4720.011% |
| PetMed Express, Inc. | -8.16 Million USD | -4189.353% |
| Walgreens Boots Alliance, Inc. | -14.07 Billion USD | 97.513% |